THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

TANG CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001232621)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 351,252 Value ($000) $6,572 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 264,308 Value ($000) $3,859 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 264,308 Value ($000) $2,915 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 262,896 Value ($000) $2,348 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 262,896 Value ($000) $2,474 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 262,896 Value ($000) $2,119 Avg Close $8.66 Range $7.44 - $10.42

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	351,252	$6,572	$16.59	$13.50 - $20.33
Q3 2025	264,308	$3,859	$12.64	$10.82 - $14.87
Q2 2025	264,308	$2,915	$9.72	$7.90 - $11.82
Q1 2025	262,896	$2,348	$9.31	$8.35 - $10.90
Q4 2024	262,896	$2,474	$9.10	$7.88 - $10.26
Q3 2024	262,896	$2,119	$8.66	$7.44 - $10.42